Family · Pharmaceutical analytical standards
Zolpidem
A hypnotic of the imidazopyridine family, one of the Z-drugs, developed in France and in use in Europe since 1988 (in the United States since 1992) for the short-term treatment of insomnia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?In some patients in a vegetative state after brain injury a paradoxical effect has been observed: instead of sedating, it seems to temporarily reawaken some functions. The phenomenon is still being studied.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
